RBC Capital raised the firm’s price target on Hologic (HOLX) to $89 from $86 and keeps a Sector Perform rating on the shares after its Q4 results and initial FY25
RBC Capital raised the firm’s price target on Hologic (HOLX) to $89 from $86 and keeps a Sector Perform rating on the shares after its Q4 results and initial FY25